Objectives: Informed consent forms are important for assisting patients in making informed choices regarding medical procedures. Because of their lengthy nature, complexity and specialised terminology, consent forms usually prove challenging for the general public to comprehend. This pilot study aims to use Chat Generative Pretrained Transformer (ChatGPT), a large language model (LLM), to improve the readability and understandability of a consent form for vaccination. Methods: The study was conducted in Italy, within the Central Tuscany Local Health Unit. Three different consent forms were selected and approved: the standard consent form currently in use (A), a new form totally generated by ChatGPT (B) and a modified version of the standard form created by ChatGPT (C). Healthcare professionals in the vaccination unit were asked to evaluate the consent forms regarding adequacy, comprehensibility and completeness and to give an overall judgement. The Kruskal–Wallis test and Dunn’s test were used to evaluate the median scores of the consent forms across these variables. Results: Consent forms A and C achieved the top scores in every category; consent form B obtained the lowest score. The median scores were 4.0 for adequacy on consent forms A and C and 3.0 on consent form B. Consent forms A and C received high overall judgement ratings with median scores of 4.0, whereas consent form B received a median score of 3.0. Conclusions: The findings indicate that LLM tools such as ChatGPT could enhance healthcare communication by improving the clarity and accessibility of consent forms, but the best results are seen when these tools are combined with human knowledge and supervision.
Identifying determinants of COVID-19 vaccine uptake is essential for developing effective strategies for promoting vaccination. This longitudinal study aimed to explore predictors of actual COVID-19 vaccine uptake in workers involved in essential services during the first lockdown period in the Prato Province (Italy). All essential workers were invited and surveyed before COVID-19 vaccine approval (96.5% participation rate). Participants were followed up to evaluate their actual COVID-19 vaccination uptake using the vaccination register. Multinomial models were performed to assess predictors of delayed vaccination or non-vaccination. A total of 691 participants were included, of whom 21.7% had delayed the vaccination and 4.4% were unvaccinated. Participants with a sufficient level of health literacy were 50.2% in the vaccinated-on-time group and 32.3% in the unvaccinated group. The multinomial model predictors of delayed vaccination were work type (OR = 0.51), age between 50 and 59 years (OR = 1.82), and influenza vaccination uptake in the last season (OR = 2.51). Predictors of being unvaccinated were work type (OR = 0.33) and attitudes related to attributing less importance to COVID-19 preventive measures (OR = 0.47). Findings showed distinct predictors for COVID-19 vaccination delay and for being unvaccinated. Being unvaccinated seems to be associated with a general skepticism toward prevention measures.
Background/Objectives: The “TROVAILMIOVACCINO” platform was developed to help adults in Italy identify vaccines recommended for them based on individual characteristics, in line with the Italian National Immunization Plan (NIP). The website directs users to an anonymous online questionnaire addressing key factors such as age, sex, pregnancy status, travel history, medical conditions, and risky behaviors. It is intended for adults aged 18 and over and can be filled out either by individuals or by others on their behalf, such as healthcare professionals. The purpose of the study was to assess the platform’s reach, the health status of users, and its ability to inform users. Methods: Data were organized into tables and analyzed using frequencies, percentages, and statistical tests to assess user demographics and health conditions. Significant differences among sociodemographic groups were evaluated using the Chi-square and Fisher’s exact tests. Results: Over 30 months, the website was accessed 1897 times, with 1622 users (85.5%) completing the questionnaire for personal interest. The majority of users were aged 18–49 years (61.5%), with a nearly equal male–female distribution. Healthcare workers represented the most common professional group (29.2%) among users. Older individuals were more likely to have the questionnaire completed by someone else. Among respondents, 25.8% reported having a single medical condition, with cardiovascular diseases (11.9%), diabetes (6.7%), and respiratory diseases (4.8%) being the most frequent. The most common risk condition reported was potential contact with newborns. Conclusions: The findings highlight the value of the platform in reaching diverse user groups and offering tailored vaccine recommendations.
9 June 2026 in Travel Medicine and Infectious Disease
In Italy Malaria is still mainly seen as a travel-related infection, with around 700 cases reported each year. We describe a severe, non-imported (cryptic) Plasmodium falciparum malaria case diagnosed in August 2024 in the Grosseto area (Tuscany) in an Italian patient with no travel to malaria-endemic countries and no alternative risk factors. Since June 2024, he had been staying in a nearby village on the Maremma coast. This is a well-known former malarious area (Italy was declared malaria-free in 1970) that remains receptive, with residual anophelism and the presence of Anopheles labranchiae, one of the most efficient malaria vectors in the Mediterranean basin. Marked thrombocytopenia was the initial clue and prompted blood smear microscopy, which showed 10% parasitaemia. The result was rapidly confirmed by LAMP and species identification. The patient was admitted and, once severe malaria was recognised, was treated immediately with intravenous artesunate, with subsequent clinical improvement. The case was promptly notified and investigated, but no index case, secondary cases, or transmission chain were identified. This episode is a reminder that receptive areas still need clinical suspicion, diagnostic readiness, and a surveillance response that can move quickly even when travel history is negative.